Drug intelligence / Profile preview

dihydrotanshinone I

Development stage
Preclinical
Lead developer
Bergen County Academies
Modality
Small Molecules
Administration
Oral
01

Overview

Dihydrotanshinone I is a bioactive lipophilic abietane diterpenoid isolated from the root of *Salvia miltiorrhiza* (Danshen), a staple of traditional Chinese medicine. It exhibits significant antineoplastic, anti-inflammatory, and cardiovascular protective properties. In oncology research, dihydrotanshinone I has demonstrated the ability to induce apoptosis in various cancer cell lines, including glioblastoma, by promoting the generation of reactive oxygen species (ROS) and inducing endoplasmic reticulum (ER) stress. It is particularly noted for its potential as a chemosensitizer; it can cross the blood-brain barrier and downregulate the expression of O6-methylguanine DNA methyltransferase (MGMT) and P-glycoprotein (P-gp), thereby enhancing the efficacy of chemotherapeutic agents like temozolomide. Furthermore, it modulates several key signaling pathways, including the inhibition of NF-κB and the PI3K/AKT pathway, to suppress tumor cell proliferation and survival.

Other names
1,2-dihydrotanshinone Idihydrotanshinone
02

Targets

ABCB1 (P-glycoprotein)AGT (O6-methylguanine-DNA methyltransferase)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on dihydrotanshinone I.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dihydrotanshinone I.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call